Equities

Amrutanjan Health Care Ltd

AMRUTANJAN:NSI

Amrutanjan Health Care Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)801.50
  • Today's Change20.50 / 2.62%
  • Shares traded31.12k
  • 1 Year change+27.20%
  • Beta1.0572
Data delayed at least 15 minutes, as of Sep 20 2024 11:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,1051,8982,011
Total Receivables, Net532367418
Total Inventory303299272
Prepaid expenses8.053.593.59
Other current assets, total8.442843
Total current assets2,9572,5952,746
Property, plant & equipment, net495475435
Goodwill, net------
Intangibles, net242523
Long term investments118431223
Note receivable - long term423822
Other long term assets--1313
Total assets3,6693,6213,499
LIABILITIES
Accounts payable559474604
Accrued expenses474440
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.325.055.69
Other current liabilities, total91107124
Total current liabilities699630775
Total long term debt144.043.11
Total debt179.098.80
Deferred income tax------
Minority interest------
Other liabilities, total717970
Total liabilities784713847
SHAREHOLDERS EQUITY
Common stock292929
Additional paid-in capital------
Retained earnings (accumulated deficit)2,8722,9232,667
Treasury stock - common(16)(45)(45)
Unrealized gain (loss)------
Other equity, total------
Total equity2,8852,9082,651
Total liabilities & shareholders' equity3,6693,6213,499
Total common shares outstanding292929
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.